Lilly Asia, Qiming, HongShan et al Double Down on Cell Therapy Tech
22 Oct 2024
US$ 19.00
Lilly Asia Ventures, Qiming Venture Partners, HongShan and FreesFund, all existing investors of XellSmart ......
Tag
Biotech
Related Publications
Accel Atoms, the pre-seed and seed platform of Accel, has announced a partnership with Google LLC’s AI Futures Fund ......
KKR & Co Inc (KKR) checked out from Hyatt Regency Tokyo in Q3 2025 and clocked a 2x return result, at ¥120 bn ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.